XML 20 R79.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended
Dec. 30, 2012
Jan. 01, 2012
Dec. 17, 2012
Nov. 08, 2012
Dec. 30, 2012
Minimum [Member]
Dec. 30, 2012
Maximum [Member]
Dec. 30, 2012
Technology assets [Member]
Dec. 30, 2012
Technology assets [Member]
Minimum [Member]
Dec. 30, 2012
Technology assets [Member]
Maximum [Member]
Dec. 30, 2012
Trade name license agreement [Member]
Dec. 30, 2012
Trade name license agreement [Member]
Minimum [Member]
Dec. 30, 2012
Trade name license agreement [Member]
Maximum [Member]
Dec. 30, 2012
Trade name [Member]
Dec. 30, 2012
Trade name [Member]
Minimum [Member]
Dec. 30, 2012
Trade name [Member]
Maximum [Member]
Dec. 30, 2012
Customer relationships [Member]
Dec. 30, 2012
Customer relationships [Member]
Minimum [Member]
Dec. 30, 2012
Customer relationships [Member]
Maximum [Member]
Dec. 30, 2012
Trademarks and trade names [Member]
Dec. 30, 2012
Trademarks and trade names [Member]
Minimum [Member]
Dec. 30, 2012
Trademarks and trade names [Member]
Maximum [Member]
Dec. 17, 2012
HHI Business [Member]
Apr. 06, 2011
FGL [Member]
Dec. 30, 2012
FGL [Member]
Dec. 30, 2012
Call Option exercisable between January 1, 2017 and March 31, 2017 [Member]
Times
Nov. 08, 2012
Shaser Biosciences, Inc. [Member]
Non-controlling Interest [Member]
Nov. 08, 2012
Shaser Biosciences, Inc. [Member]
Technology assets [Member]
Business Acquisition [Line Items]                                                      
Negotiated sales price paid                                           $ 100.0          
Inventory to fair value 31.5                                                    
Deferred tax liabilities, net 111.8                                                    
Property, plant and equipment, net 8.9                                         104.5          
Total fair value of indefinite and definite lived intangibles     470.0                                                
Estimated Income tax rate 48.60% 46.50%         35.00%     35.00%     35.00%     35.00%     35.00%             35.00% 35.00%
Discounted rate             12.00%     12.00%     12.00%     12.00%     12.00%             12.00% 11.00%
Carrying value, intangible asset             51.0     12.0     3.0     74.0     330.0               35.5
Estimated sales growth rate               2.50% 31.00%   2.50% 5.00%   2.50% 5.00% 3.00%       2.50% 5.00%         3.00% 3.00%
Customer retention rate                               95.00%                      
Amortization period, intangible asset         1 year 20 years   4 years 17 years 5 years     8 years     20 years 15 years 20 years                 13 years
Royalty rate               4.00% 5.00% 4.00%     3.50%             3.00% 5.00%           10.50%
Expected terminal year growth rate                                     2.50%                
Remaining legal life                                                       
Percentage of equity interests acquired 44.00%     56.00%                                              
Trailing revenues                                                 1.0    
Adjusted trailing EBITDA                                                 7.0    
Non-controlling interest                                                   39.0  
Cash consideration 1,295.9 183.1                                         350.0        
Reduction in purchase price                                             50.0 50.0      
Cash consideration re-characterized as expense                                             5.0        
Insurance obligations under annuity contract                                               3,000.0      
Maximum amount of asset securing reinsurance obligations                                               1,000.0      
Maximum amount required to pay under Front Street Reinsurance Transaction                                               50.0      
Fair value assigned to the contingent purchase price reduction                                               0      
Estimated a fair value for reduction in purchase price                                               $ 41.0